Bruker Statistics
Total Valuation
Bruker has a market cap or net worth of $6.65 billion. The enterprise value is $8.40 billion.
Important Dates
The next estimated earnings date is Friday, February 13, 2026, before market open.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | Dec 8, 2025 |
Share Statistics
Bruker has 151.94 million shares outstanding. The number of shares has increased by 2.43% in one year.
| Current Share Class | 151.94M |
| Shares Outstanding | 151.94M |
| Shares Change (YoY) | +2.43% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 31.92% |
| Owned by Institutions (%) | 88.67% |
| Float | 103.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 21.91 |
| PS Ratio | 1.93 |
| Forward PS | 1.89 |
| PB Ratio | 2.72 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 70.49 |
| PEG Ratio | 15.31 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.44 |
| EV / EBITDA | 14.36 |
| EV / EBIT | 22.71 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.82.
| Current Ratio | 1.85 |
| Quick Ratio | 0.84 |
| Debt / Equity | 0.82 |
| Debt / EBITDA | 3.50 |
| Debt / FCF | n/a |
| Interest Coverage | 5.72 |
Financial Efficiency
Return on equity (ROE) is -1.09% and return on invested capital (ROIC) is -23.91%.
| Return on Equity (ROE) | -1.09% |
| Return on Assets (ROA) | 3.68% |
| Return on Invested Capital (ROIC) | -23.91% |
| Return on Capital Employed (ROCE) | 7.16% |
| Weighted Average Cost of Capital (WACC) | 6.12% |
| Revenue Per Employee | $301,764 |
| Profits Per Employee | -$2,080 |
| Employee Count | 11,396 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 1.46 |
Taxes
In the past 12 months, Bruker has paid $32.20 million in taxes.
| Income Tax | 32.20M |
| Effective Tax Rate | 374.42% |
Stock Price Statistics
The stock price has decreased by -24.76% in the last 52 weeks. The beta is 1.17, so Bruker's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | -24.76% |
| 50-Day Moving Average | 48.06 |
| 200-Day Moving Average | 39.98 |
| Relative Strength Index (RSI) | 35.35 |
| Average Volume (20 Days) | 2,664,928 |
Short Selling Information
The latest short interest is 9.85 million, so 6.48% of the outstanding shares have been sold short.
| Short Interest | 9.85M |
| Short Previous Month | 10.61M |
| Short % of Shares Out | 6.48% |
| Short % of Float | 9.53% |
| Short Ratio (days to cover) | 4.47 |
Income Statement
In the last 12 months, Bruker had revenue of $3.44 billion and -$23.70 million in losses. Loss per share was -$0.16.
| Revenue | 3.44B |
| Gross Profit | 1.68B |
| Operating Income | 369.90M |
| Pretax Income | 8.60M |
| Net Income | -23.70M |
| EBITDA | 585.00M |
| EBIT | 369.90M |
| Loss Per Share | -$0.16 |
Full Income StatementBalance Sheet
The company has $295.00 million in cash and $2.05 billion in debt, with a net cash position of -$1.75 billion or -$11.55 per share.
| Cash & Cash Equivalents | 295.00M |
| Total Debt | 2.05B |
| Net Cash | -1.75B |
| Net Cash Per Share | -$11.55 |
| Equity (Book Value) | 2.49B |
| Book Value Per Share | 16.06 |
| Working Capital | 1.08B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $94.30 million and capital expenditures -$104.90 million, giving a free cash flow of -$10.60 million.
| Operating Cash Flow | 94.30M |
| Capital Expenditures | -104.90M |
| Free Cash Flow | -10.60M |
| FCF Per Share | -$0.07 |
Full Cash Flow StatementMargins
Gross margin is 48.83%, with operating and profit margins of 10.76% and -0.61%.
| Gross Margin | 48.83% |
| Operating Margin | 10.76% |
| Pretax Margin | 0.25% |
| Profit Margin | -0.61% |
| EBITDA Margin | 17.01% |
| EBIT Margin | 10.76% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $0.20, which amounts to a dividend yield of 0.46%.
| Dividend Per Share | $0.20 |
| Dividend Yield | 0.46% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.43% |
| Shareholder Yield | -1.97% |
| Earnings Yield | -0.36% |
| FCF Yield | -0.16% |
Dividend DetailsAnalyst Forecast
The average price target for Bruker is $52.08, which is 19.04% higher than the current price. The consensus rating is "Buy".
| Price Target | $52.08 |
| Price Target Difference | 19.04% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 3.21% |
| EPS Growth Forecast (5Y) | 27.39% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bruker has an Altman Z-Score of 2.51 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.51 |
| Piotroski F-Score | 5 |
